FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study

Lale Kostakoglua Department of Radiology, The Mount Sinai Hospital, New York, NY, USACorrespondence[email protected]

Andre Goyb John Theurer Cancer Center HUMC, Hackensack, NJ, USA

Giovanni Martinellic Department of Haematology-Oncology, IEO Istituto Europeo di Oncologia, Milano, Italy

Dolores Caballerod Hematology Department, University Hospital of Salamanca, Salamanca, Spain

Michael Crumpe Princess Margaret Hospital, University of Toronto, ON, Canada

Gianluca Gaidanof Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Tara Baetzg Division of Medical Oncology, Kingston General Hospital, Queen’s University, Kingston, ON, Canada

Rena Bucksteinh Sunnybrook Health Sciences Center, Toronto, ON, Canada

Gregg Finei Genentech Inc, South San Francisco, CA, USA

Guenter Fingerle-Rowsonj F. Hoffmann-La Roche, Basel, Switzerland

Claude Bergej F. Hoffmann-La Roche, Basel, Switzerland

Deniz Sahinj F. Hoffmann-La Roche, Basel, Switzerland

Oliver Pressk Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Laurie Sehnl Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada

Your download is now in progress and you may close this window